Medscape and City of Hope Partner to Arm Clinicians in the Fight Against Cancer

NEWARK, N.J. – May 20, 2026 – In a significant move to address the complexities of modern cancer care, Medscape, a leading global digital platform for clinicians, has announced a strategic collaboration with City of Hope, a world-renowned cancer research and treatment system. The partnership aims to infuse Medscape's extensive oncology resources with expert-validated insights directly from one of the nation's foremost cancer institutions, equipping healthcare professionals worldwide with the latest knowledge to navigate the rapidly evolving field.

Under the agreement, oncology experts from City of Hope will serve as authors and peer reviewers, contributing directly to Medscape's core educational and reference materials. This initiative will provide data-driven perspectives on cancer research and treatment, designed to support clinical decision-making for the millions of healthcare professionals who rely on the platform.

A Critical Need in a Rapidly Evolving Field

Oncology stands as one of the most dynamic and challenging areas of medicine. The relentless pace of discovery—from novel immunotherapies and targeted agents to new diagnostic biomarkers—creates a constant influx of information that can be overwhelming for practicing clinicians. This reality is reflected in Medscape's own user data.

"Oncology is one of the fastest-evolving areas of medicine — and the most-searched condition globally by physicians using our Medscape content," said Lori Dickerson, PharmD, Executive Director of Medscape Reference Content. This high demand underscores a critical need for curated, reliable, and easily accessible information.

Clinicians on the front lines face not only an information overload but also significant administrative burdens, persistent drug shortages, and the challenge of managing the high cost of care for patients. In this environment, having a trusted resource that synthesizes complex data into actionable insights is invaluable. Medscape's existing tools, such as its "Oncology Decision Point" which integrates guidelines from major organizations like the NCCN and ASCO, are designed to help. This new collaboration is set to significantly enhance such offerings by embedding the real-world expertise of a leading treatment center directly into the content.

By having City of Hope's team of over 700 physicians and nearly 2,000 researchers contribute, the partnership aims to ensure that the content on Medscape reflects the highest standards of clinical accuracy and aligns with current, real-world standards of care. This provides a direct line from the vanguard of cancer research to the physicians making daily treatment decisions.

Forging a New Model for Knowledge Translation

This alliance represents more than just a content enhancement; it signals a powerful new model for knowledge translation in the digital age. It creates a direct pipeline between a premier academic and research institution and a massive global distribution network. Medscape's platform, with its 13 million members, offers unparalleled reach, while City of Hope provides the deep, specialized expertise that comes from being a leader in areas like bone marrow transplantation, CAR T-cell therapy, and precision medicine.

While other platforms like UpToDate and resources from professional societies like ASCO are cornerstones of medical education, this partnership offers a unique value proposition. Instead of aggregating information from a wide array of individual experts, it integrates the collective, institutional knowledge of a center that is actively developing and delivering the next generation of cancer cures. This synergy has the potential to dramatically shorten the lag time between a research breakthrough and its widespread dissemination to practicing clinicians.

For Medscape, the collaboration solidifies its position as an authoritative source in its most in-demand specialty, providing a key differentiator in a competitive market. For City of Hope, it amplifies its educational mission on a global scale, extending its influence far beyond its physical campuses. The strategic alignment allows the institution to shape clinical practice and ensure its pioneering work informs patient care worldwide, reinforcing its brand as a leader in both treatment and education.

Fighting Cancer with Information and Equity

Perhaps the most profound impact of this partnership lies in its potential to advance health equity. Access to specialized oncology knowledge is not uniform; clinicians in smaller, rural, or underserved communities may not have the same access to continuing education or peer networks as their counterparts in major urban medical centers. By delivering expert-validated, cutting-edge information on a free and globally accessible platform, this initiative works to democratize expertise.

This goal was highlighted by Dr. Vijay Trisal, City of Hope's system chief clinical officer. "As cancer care evolves at an unprecedented pace, it is critical that clinicians have access to timely, trusted insights that reduce and eliminate inequities in cancer outcomes," he stated. "Through this collaboration with Medscape, City of Hope is helping deliver the latest evidence and clinical perspectives directly to healthcare professionals, supporting more informed cancer care decisions and better outcomes for patients."

When a clinician in any setting can access insights derived from City of Hope's extensive clinical trial programs and patient data, it helps level the playing field. This improved access can lead to more accurate diagnoses, better treatment choices, and the adoption of higher standards of care across diverse geographic and economic landscapes. Ultimately, arming clinicians with better information is a direct investment in better patient outcomes. By bridging the knowledge gap, the collaboration between Medscape and City of Hope aims to ensure that a patient's quality of care is not determined by their zip code. The shared commitment is clear: to elevate the quality and accessibility of oncology information, creating a more informed and better-equipped global community of healthcare professionals dedicated to fighting cancer.